| Serum amyloid protein A in inflammatory bowel disease: from bench to bedside R Chen, Q Chen, J Zheng, Z Zeng, M Chen, L Li, S Zhang Cell Death Discovery 9 (1), 154, 2023 | 25 | 2023 |
| Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation R Chen, X Pang, L Li, Z Zeng, M Chen, S Zhang Cell Death & Disease 13 (2), 139, 2022 | 22 | 2022 |
| Suberoylanilide hydroxamic acid sensitizes neuroblastoma to paclitaxel by inhibiting thioredoxin‐related protein 14‐mediated autophagy Z Zhen, K Yang, L Ye, Z You, R Chen, Y Liu, Y He Cancer Science 108 (7), 1485-1492, 2017 | 19 | 2017 |
| Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: Pathophysiology and therapeutic targets Y Tie, Y Huang, R Chen, L Li, M Chen, S Zhang Gut Microbes 15 (2), 2265028, 2023 | 13 | 2023 |
| Metabolomics facilitate the personalized management in inflammatory bowel disease R Chen, J Zheng, L Li, C Li, K Chao, Z Zeng, M Chen, S Zhang Therapeutic Advances in Gastroenterology 14, 17562848211064489, 2021 | 13 | 2021 |
| A novel model based on serum biomarkers to predict primary non-response to infliximab in Crohn’s disease L Li, R Chen, Y Zhang, G Zhou, B Chen, Z Zeng, M Chen, S Zhang Frontiers in Immunology 12, 646673, 2021 | 13 | 2021 |
| Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1 Z Zhen, K Yang, L Ye, Z You, R Chen, Y Liu Investigational New Drugs 35 (5), 566-575, 2017 | 8 | 2017 |
| Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions R Chen, Y Tie, J Lu, L Li, Z Zeng, M Chen, S Zhang Cell Proliferation 55 (5), e13222, 2022 | 6 | 2022 |
| Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease R Chen, L Li, K Chao, M Hong, Q Cao, L Ye, G Zhou, X Fang, H Guo, ... Therapeutic Advances in Gastroenterology 13, 1756284820979442, 2020 | 5 | 2020 |
| Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials R Chen, Y Tie, X Zhang, L Li, M Chen, S Zhang United European Gastroenterology Journal 11 (6), 542-550, 2023 | 4 | 2023 |
| HLA-E inhibitor enhances the killing of neuroblastoma stem cells by co-cultured dendritic cells and cytokine-induced killer cells loaded with membrane-based microparticles Z Zhen, K Yang, L Ye, Z You, R Chen, Y Liu, Y He American Journal of Cancer Research 7 (2), 334, 2017 | 4 | 2017 |
| Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis R Chen, L Li, Y Tie, M Chen, S Zhang Precision Clinical Medicine 6 (3), pbad022, 2023 | 3 | 2023 |
| Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal R Chen, J Zheng, C Li, Q Chen, Z Zeng, L Li, M Chen, S Zhang Frontiers in Immunology 14, 1215116, 2023 | 3 | 2023 |
| Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions R Chen, C Li, K Chao, Y Tie, J Zheng, H Guo, Z Zeng, L Li, M Chen, ... Therapeutic Advances in Gastroenterology 16, 17562848231165129, 2023 | 2 | 2023 |
| Prealbumin and Retinol-Binding protein 4: the promising inflammatory biomarkers for identifying Endoscopic Remission in Crohn’s Disease R Chen, L Li, C Li, Y Su, Y Zhang, X Pang, J Zheng, Z Zeng, MH Chen, ... Journal of Inflammation Research, 7371-7379, 2021 | 2 | 2021 |
| Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes R Chen, Y Tie, Y Huang, X Zhang, Z Zeng, M Chen, L Li, S Zhang United European Gastroenterology Journal 12 (4), 459-468, 2024 | | 2024 |
| Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease G Zhou, R Chen, Y Jiang, L Li, J Zheng, C Li, S Zhang, M Chen Therapeutic Advances in Gastroenterology 15, 17562848221089096, 2022 | | 2022 |
| Platelet-to-Lymphocyte Percentage Ratio (PLpR) for Assessing Disease Activity and Predicting Therapeutic Outcomes in Ulcerative Colitis J Zheng, Y Wang, L Li, M Chen, R Chen, S Zhang Available at SSRN 4558633, 0 | | |
